UK Cystic Fibrosis Survey 1993 Report,The Cystic Fibrosis Trust, 1993.
2.
BlairC, CullA, FreemanC.Psychosocial functioning of young adults with cystic fibrosis and their families.Thorax1994; 49: 798–802.
3.
HuntS, McEwenJ, McKennaSMeasuring health status.London: Croom Helm,1986.
4.
BergnerM, BobbittR, CarterWThe Sickness Impact Profile: development and final version of a health status measure.Medical Care1981; 19: 787–805.
5.
WareJ, SherbourneC.The Mos 36-item short-form health survey: Conceptual framework and item selection.Medical Care1992;30: 473–81.
6.
McKennaS.A new theoretical approach to the measurement of quality of life.Drug Information J1994; 28: 13–18.
7.
AbbottJ, BiltonD, DoddM, WebbA.Treatment compliance in adults with cystic fibrosis.Thorax1994; 49: 115–20.
8.
TorranceG.Measurement of health state utilities for economic appraisal.J Health Economics1986; 5: 1–30.
9.
DeanM.Is your treatment economic, effective, efficient?Lancet1991; 337: 480–1.
10.
JonesP.Issues concerning health-related quality of life in COPD.Chest1995; 107: 187S–193S.
11.
OrensteinD, NixonP, RossE, KaplanR.The quality of well-being in cystic fibrosis.Chest1989; 95: 344–7.
12.
GriecoA, LongC.Investigation of the Karnofsky Performance Status as a measure of quality of life.Health Psychol1984; 3: 129–42.
13.
The Euroquol Group.Euroqol: a new facility for the measurement of health-related quality of life.Health Policy1990; 16: 199–208.
14.
GuyattG, BermanL, TownsendMA measure of quality of life for clinical trials in chronic lung disease.Thorax1987; 42: 773–8.
15.
JonesP, QuirkF, BaveystockC, LittlejohnsP.A self-complete measure for chronic airflow limitation—the St George's Respiratory Questionnaire.Am Rev Respir Dis1992; 145: 1321–7.
16.
JuniperE, GuyattG, EpsteinR, FerrieP, JacschkeR, HillerT.Evaluation of impairment of health rated quality of life in asthma: development for a questionnaire for use in clinical trials.Thorax1992; 47: 76–83.
17.
WeirD, FreemanW, RobertsK, StableforthD.Comparison of a measure of quality of life in patients with cystic fibrosis and chronic airflow obstruction.Thorax1991; 46: 288P.
OrensteinD, PattishallE, NixonP, RossE, KaplanR.Quality of well-being before and after antibiotic treatment of pulmonary exacerbation in patients with cystic fibrosis.Chest1990; 98: 1081–4.
20.
OrensteinD, KaplanR.Measuring the quality of well-being in cystic fibrosis and lung transplantation: the importance of the area under the curve.Chest1991; 100: 1016–8.
21.
ShepherdS, HovellM, SlymenDFunctional status as an overall measure of health in adults with cystic fibrosis: further validation for a generic health measure.J Clin Epidemiol1992; 45: 117–25.
22.
CongletonJ, HodsonM, Duncan-SkingleF.Quality of life in adults with cystic fibrosis.Thorax1996; 51: 936–40.
23.
CaineN, SharpiesL, SmythRSurvival and quality of life of cystic fibrosis patients before and after heart-lung transplantation.Transpl Proc1991; 23: 1203–4.
24.
DennisC, CaineN, SharpiesLHeart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital.J Heart Lung Transpl1993; 12: 893–902.
25.
BusschbachJ, HorikxP, van der BoschJ, Brutel de la LiviereA, de CharroF.Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis.Chest1994; 105: 911–7.
26.
HeijermanH, RossemR, BakkerW.Effect of rhDNase on lung function and quality of life in adult cystic fibrosis patients.Netherlands J Med1995; 46: 293–7.
27.
AbortJ, DoddM, WebbA.Different perceptions of disease severity and self care between patients with cystic fibrosis, their close companions, and physician.Thorax1995; 50: 794–6.
28.
EigenH, ClarkN, WolleyJ.NHLBI Workshop summary: Clinical behavioural aspects of cystic fibrosis: directions for future research.Am Rev Respir Dis1987; 136: 1509–13.
29.
JaeschkeR, SingerJ, GuyattG.Measurement of health status: Ascertaining the minimal clinically important difference.Controlled Clin Trials1989; 10: 407–15.